Clinical trial
Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction…
NCT00212004 · National Cerebral and Cardiovascular Center, Japan, Other · Terminated
Key facts
| NCT number | NCT00212004 |
|---|---|
| Title | Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study) |
| Official title | The Japan Working Group for the Assessment That the Pioglitazone Protects DM Patients Against Re-Infarction |
| Lead sponsor | National Cerebral and Cardiovascular Center, Japan, Other |
| Collaborators | Japan Heart Foundation |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Myocardial Infarction |
| Intervention type | Drug, Other |
| Interventions | pioglitazone, control |
| Enrollment | 630 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2017 |
| Completion | Apr 1, 2018 |
| First posted | Sep 21, 2005 |
| Last update posted | May 23, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: